# Director Genomics Shared Resource

> **NIH NIH R50** · ROSWELL PARK CANCER INSTITUTE CORP · 2024 · $236,003

## Abstract

PROJECT SUMMARY / ABSTRACT
The current application seeks salary support for Prashant K. Singh, PhD who serves as the Director of the
Genomics Shared Resource (GSR) at Roswell Park Comprehensive Cancer Center (Roswell Park) and
Assistant Professor in the Department of Cancer Genetics and Genomics. Dr. Singh works closely with Cancer
Center Support Grant (CCSG) leadership and members to provide a centralized, efficient approach of supporting
research, clinical and population based genomic endeavors, while facilitating peer-reviewed funding,
publications, and recruitment efforts. Dr. Singh supports all genomics initiatives at Roswell Park by providing
expertise in all aspects of assay design, sample preparation, QC, data generation, and analyses. Dr. Singh acts
as a subject matter expert for CCSG members utilizing genomics approached to acquire and analyze genomic
data sets across basic, translational, clinical and population studies. Dr. Singh plays a vital role in discovery-
driven research of CCSG members as well as in diagnostic applications that complement traditional clinical
evaluation of cancer samples. Dr. Singh is involved in the research and design of NGS assays that support the
goals of developing personalized therapies based on the unique genetic makeup of a patient’s cancer. The GSR
is an integral part of Roswell Park’s CCSG (P30CA016056) for which the cancer center Director, Dr. Candace
Johnson, serves as the Principal Investigator. In the current CCSG reporting period (2018-present), as of
October 2023, 128 NIH/NCI grant applications utilizing the GSR services and Dr. Singh’s expertise were awarded
to Roswell Park faculty. In the same period, the GSR contributed to 210 peer reviewed publications. Dr. Singh
has over 19 years of experience in the field of genomics and epigenomics with a strong focus in cancer research.
Dr. Singh actively participates in meetings focused on correlative sciences related to clinical trials, multi-PI, and
multi-institutional programs such as the Roswell Park Ovarian SPORE (P50CA159981-08), P01 Program grant
(P01CA234212), and the Western New York Center for Research on Flavored Tobacco Products (CRoFT,
U54CA228110). Dr. Singh’s leadership and expertise is critical for continued success of the CCSG program and
Roswell Park’s research mission. As the PI of Roswell Park’s CCSG (P30CA016056), Dr. Johnson will serve
as the Unit Director for this R50 Core-based scientist (PAR-22-188) application.

## Key facts

- **NIH application ID:** 10977529
- **Project number:** 1R50CA283805-01A1
- **Recipient organization:** ROSWELL PARK CANCER INSTITUTE CORP
- **Principal Investigator:** Prashant Kumar Singh
- **Activity code:** R50 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $236,003
- **Award type:** 1
- **Project period:** 2024-09-01 → 2029-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10977529

## Citation

> US National Institutes of Health, RePORTER application 10977529, Director Genomics Shared Resource (1R50CA283805-01A1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10977529. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*